chr1-215766680-C-T
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1_ModeratePP5_Very_Strong
The NM_206933.4(USH2A):c.11047+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.00000806 in 1,612,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_206933.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- Usher syndrome type 2Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Usher syndrome type 2AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- retinitis pigmentosa 39Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| USH2A | ENST00000307340.8 | c.11047+1G>A | splice_donor_variant, intron_variant | Intron 56 of 71 | 1 | NM_206933.4 | ENSP00000305941.3 | |||
| USH2A | ENST00000674083.1 | c.11047+1G>A | splice_donor_variant, intron_variant | Intron 56 of 72 | ENSP00000501296.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152084Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460556Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 726662 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152084Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74274 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:3
This sequence change affects a donor splice site in intron 56 of the USH2A gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is present in population databases (rs201730567, gnomAD 0.007%). Disruption of this splice site has been observed in individuals with clinical features of USH2A-related conditions (PMID: 22135276; internal data). ClinVar contains an entry for this variant (Variation ID: 501315). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
- -
Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 35457016, 24603341, 22135276, 31964843, 35266249) -
Retinitis pigmentosa 39 Pathogenic:3
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
- -
- -
Usher syndrome Pathogenic:1
Variant summary: USH2A c.11047+1G>A is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes the canonical 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 251340 control chromosomes. c.11047+1G>A has been reported in the literature in individuals affected with Usher Syndrome (example, Le Quesne Stabej_2012, Maranhao_2014). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 22135276, 24603341). ClinVar contains an entry for this variant (Variation ID: 501315). Based on the evidence outlined above, the variant was classified as pathogenic. -
Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Pathogenic:1
- -
Retinal dystrophy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at